Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers Drugs Comparisons API
Trackers› Clinical trials› Limerick
Clinical trial register · Ireland

Clinical Trials in Limerick, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Ireland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Alert me on this filter Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 602 matching records held by the registry are in this view. Synced 16 Oct 2026, 03:15 UTC
602
Studies in scope
all four open statuses
302
Recruiting now
open to new participants
164
Lead sponsors
across recruiting studies
37
Irish site locations
across all listed studies
Phase mix of the 302 recruiting studies
Phase 3 94 Not applicable 74 Observational 71 Phase 2 23 Phase 1/2 21 Other 19
Narrow the register Reset
Matches title, registry number, sponsor, intervention and condition.
Recruitment status
Phase
Lead sponsor
University of Limerick 10 Royal College of Surgeons, Ireland 4 Merck Sharp & Dohme LLC 3 Cancer Trials Ireland 3 Mirati Therapeutics Inc. 2
Site location
Dublin 484 Cork 169 Galway 125 Limerick 56 Waterford 52
All 37 locations
Target enrolment
to

Trials with a site in Limerick

56 of 602 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Irish sites
Start
Recruiting
Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests
NCT07106632 Early Breast Cancer, Premenopausal Breast Cancer, HR+/HER2- Breast Cancer
UNICANCER
Phase 3
3,380
Cork, Dublin, Limerick, Tullamore, Waterford
2026-06-26
Recruiting
Glycolytic Phenotype (vLapeak) and Magnitude of Skeletal Muscle Hypertrophy After Resistance Training
NCT07721766 Healthy Volunteers, Muscle Hypertrophy, Glycolysis, Moderately Trainend
Technical University of Munich
Not applicable
120
Limerick
2026-05-04
Recruiting
Frailty in Older Adults With Prostate Cancer: a Prospective Cohort Study
NCT07605936 Frailty at Older Adults, Prostate Cancer
University of Limerick
Observational
80
Limerick
2026-04-23
Recruiting
University of Limerick
Observational
150
Limerick
2026-01-05
Recruiting
European Myeloma Network B.V.
Phase 3
1,000
Cork, Dublin, Limerick
2025-12-23
Recruiting
BeOne Medicines
Phase 3
630
Dublin, Galway, Limerick
2025-06-11
Recruiting
Takeda
Phase 3
225
Cork, Dublin, Limerick
2025-05-06
Recruiting
Merck Sharp & Dohme LLC
Phase 2
594
Dublin, Limerick, Waterford
2025-04-11
Recruiting
University of Limerick
Observational
100
Limerick
2025-02-22
Recruiting
University of Limerick
Observational
150
Limerick
2025-02-10
Active, closed
A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study)
NCT06680817 Neovascular Age-related Macular Degeneration, Diabetic Macular Edema
DrugsVabysmo·Faricimab
Hoffmann-La Roche
Observational
875
Dublin, Limerick, Waterford
2025-02-05
Not yet open
University of Limerick
Observational
650
Limerick
2025-02-01
By invitation
Hidde van der Ploeg
Not applicable
100
Limerick
2024-12-01
Active, closed
Genmab
Phase 3
191
Cork, Dublin, Limerick, Waterford
2024-11-25
Recruiting
ENVELOP: Wound Care Following Pilonidal Sinus Surgery
NCT06647290 Pilonidal Sinus, Wound Healing
Royal College of Surgeons, Ireland
Not applicable
200
Castlebar, Dublin, Kilkenny, Limerick, Tullamore, Waterford
2024-10-01
Recruiting
University of Limerick
Not applicable
72
Limerick
2024-09-01
Recruiting
PINTA - Prophylactic Incisional Negative Pressure Therapy for Major Amputations
NCT06025253 Wound Surgical, Wound Infection, Cosmesis
Royal College of Surgeons, Ireland
Not applicable
728
Dublin, Galway, Limerick, Waterford
2024-03-01
Active, closed
University of Limerick
Not applicable
106
Limerick
2024-01-15
Recruiting
University of Limerick
Observational
150
Dublin, Galway, Limerick, Tipperary
2024-01-11
Active, closed
Cancer Trials Ireland
Phase 2
11
Galway, Dublin, Cork, Limerick
2023-10-26
Active, closed
University of Limerick
Not applicable
10
Limerick
2023-08-07
Active, closed
PROPEL-2: Prophylactic Negative Pressure Wound Therapy in Laparotomy Wounds
NCT05977816 Wound Surgical, Wound Infection, Cosmesis
Royal College of Surgeons, Ireland
Not applicable
2,000
Castlebar, Dublin, Galway, Letterkenny, Limerick, Sligo, Waterford
2023-07-14
Recruiting
Early Detection & Intervention of Cerebral Palsy in Ireland
NCT05907837 Cerebral Palsy, Neurodevelopmental Disorders
University College Cork
Observational
1,500
Cork, Dublin, Limerick
2023-07-01
Active, closed
ETOP IBCSG Partners Foundation
Phase 2
68
Dublin, Limerick, Waterford
2023-06-12
Recruiting
Gilead Sciences
Phase 3
1,514
Dublin, Limerick, Wilton
2022-12-12
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
822
Cork, Dublin, Limerick
2022-11-08
Recruiting
Celgene
Phase 3
810
Galway, Cork, Dublin, Limerick
2022-09-20
Active, closed
AstraZeneca
Phase 3
594
Cork, Dublin, Limerick
2022-09-15
Recruiting
Institute of Cancer Research, United Kingdom
Phase 3
1,128
Cork, Dublin, Limerick
2022-09-09
Recruiting
European Myeloma Network B.V.
Phase 3
1,594
Cork, Dublin, Galway, Limerick
2022-09-08
Recruiting
UNICANCER
Phase 3
300
Dublin, Limerick
2022-04-19
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Cork, Dublin, Galway, Limerick, Waterford
2021-08-27
Active, closed
Incyte Corporation
Phase 3
899
Dublin, Limerick
2021-05-11
Recruiting
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
NCT04728893 Hematologic Malignancies, Waldenstroms Macroglobulinaemia, Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia
DrugNemtabrutinib
Merck Sharp & Dohme LLC
Phase 2
490
Dublin, Limerick
2021-04-05
Active, closed
German CLL Study Group
Phase 3
897
Cork, Dublin, Galway, Limerick, Waterford
2021-03-01
Active, closed
Mirati Therapeutics Inc.
Phase 3
453
Tallaght, Dublin, Galway, Limerick
2021-02-23
Active, closed
Daiichi Sankyo
Phase 3
1,600
Dublin, Cork, Limerick
2020-12-04
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Cork, Dublin, Galway, Limerick, Waterford
2020-12-02
Active, closed
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
NCT04595565 HER2-negative Breast Cancer, Triple Negative Breast Cancer
DrugsXeloda·Sacituzumab Govitecan·Paraplatin·Capecitabine
GBG Forschungs GmbH
Phase 3
1,332
Cork, Dublin, Limerick, Waterford
2020-10-28
Active, closed
Real World Clinical Outcomes With Novel Modulator Therapy Combinations in People With CF (RECOVER)
NCT04602468 Cystic Fibrosis, Cystic Fibrosis Liver Disease, Cystic Fibrosis in Children, Adherence, Medication
DrugElexacaftor/Tezacaftor/Ivacaftor
Royal College of Surgeons, Ireland
Phase 4
206
Dublin, Limerick, Tallaght
2020-09-03
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
777
Cork, Dublin, Galway, Limerick
2019-12-20
Active, closed
BeOne Medicines
Phase 3
510
Cork, Dublin, Galway, Limerick, Waterford
2019-08-20
Recruiting
Bristol-Myers Squibb
Phase 2
1,500
Dublin, Limerick
2019-08-09
Active, closed
Bristol-Myers Squibb
Phase 3
839
Dublin, Limerick
2019-08-05
Recruiting
University Hospital of Limerick
Observational
50
Limerick
2019-01-21
Active, closed
Feasibility Study of the Pilot Post-primary Active School Flag (PPASF) Program
NCT03847831 Physical Activity, Health Behavior, Health Knowledge, Attitudes, Practice, Educational Problems
University of Limerick
Not applicable
9,000
Limerick
2018-09-01
Active, closed
pharmaand GmbH
Phase 3
1,097
Cork, Limerick, Waterford
2018-05-14
Active, closed
Merck Sharp & Dohme LLC
Phase 3
797
Wilton, Dublin, Limerick
2018-04-24
Recruiting
University Hospital of Limerick
Observational
300
Limerick
2016-01-01
Active, closed
University College, London
Phase 3
11,000
Cork, Dublin, Galway, Limerick, Sligo, Waterford
2015-10
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
5,796
Cork, Dublin, Limerick, Sligo, Waterford
2015-08
Active, closed
ETOP IBCSG Partners Foundation
Not applicable
518
Dublin, Galway, Limerick, Waterford
2014-12-04
Active, closed
TAILORx Tissue Bank
NCT02050750 Breast Cancer
Cancer Trials Ireland
Observational
600
Cork, Donegal, Dublin, Galway, Limerick, Sligo, Waterford
2013-12
Recruiting
Breast Cancer Proteomics and Molecular Heterogeneity
NCT01840293 Primary Breast Cancer, Recurrent/Metastatic Breast Cancer
Cancer Trials Ireland
Observational
1,780
Cork, Dublin, Limerick, Waterford
2013-02
Active, closed
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
NCT01272037 Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Multicentric Breast Carcinoma, Multifocal Breast Carcinoma
DrugsTamoxifen Citrate·Tamoxifen·Exemestane·Anastrozole
National Cancer Institute (NCI)
Phase 3
5,018
Cork, Dublin, Mount Merrion, Galway, Limerick, Sligo, Waterford, Letterkenny
2011-02-28
Active, closed
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
NCT00310180 Breast Adenocarcinoma, Hormone Receptor Positive, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7
DrugsTamoxifen Citrate·Tamoxifen·Exemestane·Anastrozole
National Cancer Institute (NCI)
Phase 3
10,273
Cork, Dublin, Mount Merrion, Galway, Limerick, Sligo, Waterford, Letterkenny
2006-04-07
Rows per page Showing 1–56 of 56
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Irish investigative site, filtered. Derived from ClinicalTrials.gov, U.S. National Library of Medicine. Retrieved 16 October 2026. https://priyalifescience.com/clinical-trials-ireland/city/limerick

Query this register directly
GET /api/trials?country=ie&status=recruiting&phase=Phase+3&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Ireland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 602 studies in total at the last sync on 16 Oct 2026, 03:15 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 56 of those studies with a site in Limerick.

How many clinical trials are recruiting in Limerick?

26 of the 56 studies on this page are recruiting new participants as of the 16 Oct 2026, 03:15 UTC sync. A further 1 have not yet opened recruitment, 28 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Limerick), 56 studies
PhaseStudiesRecruitingShare
Phase 327948.2%
Observational12921.4%
Not applicable10417.9%
Phase 2538.9%
Phase 2/3111.8%
Phase 4101.8%

Most active sponsors

Lead sponsors with the most studies (Limerick)
Lead sponsorStudiesRecruiting
University of Limerick106
Royal College of Surgeons, Ireland42
Cancer Trials Ireland31
Merck Sharp & Dohme LLC32
BeOne Medicines21
Bristol-Myers Squibb21
ETOP IBCSG Partners Foundation20
European Myeloma Network B.V.22
Hoffmann-La Roche20
Mirati Therapeutics Inc.21
Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. For trials across the wider EU, see the EU Clinical Trials Tracker.